ProPhase Labs Inc. has announced the appointment of Carolina Abenante as an independent director on its Board, filling an existing vacancy. Additionally, Ms. Abenante has been appointed as a member of the Nominating and Corporate Governance Committee and as Chair of the Compensation Committee. These appointments are effective from June 20, 2025, with her term set to expire at the Company's annual meeting on July 18, 2025, where she has been nominated for re-election. Ms. Abenante brings extensive experience in technology and advertising, having founded NYIAX, Inc. and held various leadership roles in the industry.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.